Emily S Gorell (Emily Gorell)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 4

Top Topics

Intellectual Disability

Patient Reported Outcomes

Top Venues

Pediatric dermatology

Journal of the European Academy of Dermatology and Venereology : JEADV

Orphanet journal of rare diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Utako Okata-Karigane, Pirunthan Pathmarajah, Emily S Gorell, Katie Sum, Kiana Yekrang, Michelle Phung, Melissa Barriga, Patricia Udrizar, Irene Bailey, Shufeng Li, Ying Lu, Jean Y Tang, Albert S Chiou
Evaluation of antipruritic effects of serlopitant, a neurokinin 1 receptor antagonist, in patients with epidermolysis bullosa: A phase 2 randomized controlled trial. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Jodi Y So, Jaron Nazaroff, Chinonso V Iwummadu, Nicki Harris, Emily S Gorell, Shivali Fulchand, Irene Bailey, Daniel McCarthy, Zurab Siprashvili, M Peter Marinkovich, Jean Y Tang, Albert S Chiou
Long-term safety and efficacy of gene-corrected autologous keratinocyte grafts for recessive dystrophic epidermolysis bullosa. Orphanet journal of rare diseases 17 (1) (2022)
Shivali Fulchand, Nicole Harris, Shufeng Li, Melissa Barriga, Emily S Gorell, Mark De Souza, Dedee Frances Murrell, M Peter Marinkovich, Vamsi Krishna Yenamandra, Jean Y Tang
Patient-reported outcomes and quality of life in dominant dystrophic epidermolysis bullosa: A global cross-sectional survey. Pediatric dermatology 38 (5) (2021)
Emily S Gorell, Paige W Wolstencroft, Mark P de Souza, Dedee F Murrell, Eleni Linos, Jean Y Tang
Financial burden of epidermolysis bullosa on patients in the United States. Pediatric dermatology 37 (6) (2020)